Clinical Trials in Edegem, Antwerp

13 recruiting

Showing 113 of 13 trials

Recruiting
Phase 1

A Study to Compare the Blood Levels and Safety of Tazemetostat in Participants With Advanced Cancer and Moderate/Severe Liver Impairment to Participants With Advanced Cancer and Normal Liver Function

Advanced Malignant Solid TumorHepatic Impairment
Epizyme, Inc.24 enrolled18 locationsNCT04241835
Recruiting
Not Applicable

ProLARS Trial: Prospective Longitudinal Follow-up of Low Anterior Resection Syndrome (LARS) and COREFO Score After Rectum Surgery in Patients Undergoing Upfront Surgery or Different Neo-adjuvant Treatment Regimens

Rectal AdenocarcinomaLARS - Low Anterior Resection SyndromeLow Anterior Resection+2 more
University Hospital, Antwerp100 enrolled1 locationNCT07339904
Recruiting
Phase 2

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

Endometrioid Ovarian CancerFallopian Tube CancerEpithelial Ovarian Cancer+1 more
TORL Biotherapeutics, LLC230 enrolled66 locationsNCT06690775
Recruiting

Observational Study Protocol: LIVER-R

Hepatobiliary Cancers
AstraZeneca4,490 enrolled138 locationsNCT06252753
Recruiting
Phase 1Phase 2

Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

Endometrial CancerRecurrent Ovarian CancerLow Grade Serous Ovarian Cancer+3 more
Regeneron Pharmaceuticals890 enrolled51 locationsNCT03564340
Recruiting
Phase 2Phase 3

INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC

Head and Neck Squamous Cell Carcinoma (HNSCC)
Inhibrx Biosciences, Inc410 enrolled88 locationsNCT06295731
Recruiting

Compairing R-ICNB and C-ICNB for Postoperative Pain Management After Minimal-invasive Anatomical Lung Resection

Postoperative Pain ManagementRATS Surgery
University Hospital, Antwerp6 enrolled1 locationNCT07099469
Recruiting
Phase 1Phase 2

NEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a Feasibility Study

Mesothelioma; PleuraNeoadjuvant ChemoimmunotherapyPleural Epithelioid Mesothelioma
University Hospital, Antwerp37 enrolled1 locationNCT07121374
Recruiting
Not Applicable

Identifying Biomarkers for Endothelial Dysfunction in Women With Preeclampsia

Endothelial Function (FMD)PreeclampsiaRetinal Vessels
University Hospital, Antwerp60 enrolled1 locationNCT07084727
Recruiting
Phase 1Phase 2

Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma

Malignant Pleural Mesothelioma
University Hospital, Antwerp15 enrolled3 locationsNCT05765084
Recruiting
Not Applicable

Exercise Capacity Improvement by Conduction System Pacing in heArt Failure patieNts Without Compelling CRT inDication

Heart Failure With Reduced Ejection FractionHeart Failure With Preserved Ejection FractionHeart Conduction Disorder
University Hospital, Antwerp75 enrolled1 locationNCT06278844
Recruiting
Phase 1

Treatment With ABT-199 (Venetoclax) and Purine Analogues in Relapsed/Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia, in RelapseAcute Myeloid Leukemia, Refractory
University Hospital, Antwerp10 enrolled2 locationsNCT05506332
Recruiting

Prospective Athlete's Heart Study

Athlete Heart
Universitaire Ziekenhuizen KU Leuven450 enrolled4 locationsNCT05164328